Le Lézard
Classified in: Health, Business
Subjects: FNC, MAT

Planet 13 Extends $1.26 Million Loan Against Clark County Facilities and Secures Right of First Refusal to Purchase the Facilities


LAS VEGAS, July 19, 2018 /CNW/ - Planet 13 Holdings Inc. (CSE: PLTH) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company announced today that MM Development Company, Inc. ("MMDC"), the Nevada wholly owned subsidiary of Planet 13, loaned (the "Loan") US$1.26 million to Fargo District Holdings, LLC ("Fargo"), and further obtained a right of first refusal to purchase the real estate facilities (the "Real Estate Facilities") at 4280 Wagon Trail Drive, Las Vegas, Nevada 89108.

The Real Estate Facilities are currently for sale. By extending a loan to Fargo and obtaining a right of first refusal to purchase the Real Estate Facilities, Planet 13 has ensured that it is well-positioned to continue to grow its supply of international award-winning cannabis strains1, on an uninterrupted basis, throughout and following the sale process.

Fargo is owned by Larry Scheffler, co-CEO and co-Chairman of the board of directors of Planet 13. Fargo holds the Real Estate Facilities which are subject to a long-term lease with MMDC and also holds MMDC's Clark County cultivation facilities.  The Loan was made to extinguish a prior loan when the lender required repayment.

The Loan and its terms were reviewed and unanimously approved by the independent directors of Planet 13 after obtaining a certified appraisal on the Real Estate Facilities valued at US$3.6 million. The secured promissory note has a term of 20 years, with the interest rising from 3.95% after the first year to 8% thereafter.  The promissory note is secured by the Real Estate Facilities, a personal guarantee by Mr. Scheffler, a collateral assignment of rents and leases, and a deed of trust which is currently being prepared and recorded in favor of MMDC. The Loan can be repaid by Mr. Scheffler at any time without penalty.

Since Mr. Scheffler is considered a "related party" of Planet 13 under Multilateral Instrument 61-101 ? Protection of Minority Security Holders in Special Transactions ("MI 61-101") as co-CEO, a director and holder of more than 10% of the equity of Planet 13, his participation in the Loan constitutes a "related party transaction" as defined under MI 61-101. The Loan is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the Loan does not exceed 25% of Planet 13's market capitalization. A material change report was not filed more than 21 days prior to closing of the Loan due to the timing of the decision to make the Loan, the announcement and the closing all occurring in less than 21 days.

For more information, please visit https://www.planet13holdings.com/ and follow on Instagram planet13dispensary, Facebook Planet 13 Las Vegas and Twitter @Planet13lv.

(1)

2nd PlaceChloeIC Mag 420 Cup Flower2017


3rd PlaceMillion Dollar BabyIC Mag 420 Cup Flower2017


1st PlaceChloeIC Mag 420 Cup Flower2015


2nd PlaceChloeIC Mag 420 Cup Hash2015


3rd PlaceChloeIC Mag 420 Cup Flower2014

 

About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world class dispensary operations, and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH.

Cautionary Note Regarding Forward-Looking Information

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, future expansion plans.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MMDC. Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's Listing Statement dated May 24, 2018 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Planet 13


These press releases may also interest you

at 12:32
The countdown has begun for Northern Colorado's most exhilarating fitness competition of the year as "Health4Heroes" gears up to host its highly anticipated 3rd Annual Military and First Responder-inspired "Guardian Games & Expo" on Saturday, May 18,...

at 12:06
A Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum products was responsible for a former service station...

at 12:05
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...



News published on and distributed by: